{"database": "lobbying", "table": "lobbying_activities", "rows": [[1225190, "f1addf39-bef3-4e58-9e66-ae4e58f2fbf0", "Q1", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2012, "first_quarter", "HCR", "Implementation of the Health Reform Law with a focus on regulations related to the medical loss ratio (MLR), Accountable Care Organizations, Transparency, E-prescribing,  Health Information Technology, and Essential Health Benefits.\n\nReauthorization of the Prescription Drug User Fee Act, specifically issues related to track and trace policies and exclusivity. Issues related to pathways for biogenerics in both domestic and international arenas.\n\nProposed OPM-focused policies in the Administration's 2013 Budget related to the utilization of Pharmacy Benefit Managers.", "Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2012-04-11T16:29:49.920000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1225190"], "units": {}, "query_ms": 0.37725805304944515, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}